HEARTSCIENCES INC (HSCS) Stock News

USA - Nasdaq - NASDAQ:HSCS - US42254E3027 - Common Stock

2.67 USD

-0.14 (-4.98%)

Last: 11/26/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

HSCS Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: HeartSciences Inc.

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

3 months ago - By: HeartSciences Inc.

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

3 months ago - By: HeartSciences Inc.

HeartSciences Announces Conference Participation and Investor Webinar

3 months ago - By: HeartSciences Inc.

HeartSciences Announces Conference Participation and Investor Webinar

4 months ago - By: HeartSciences Inc.

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

4 months ago - By: HeartSciences Inc.

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

4 months ago - By: Benzinga - Mentions: CYH ABP APRE CASI ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

4 months ago - By: Benzinga - Mentions: ACHC REPL MEDP IOVA ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

6 months ago - By: Stocktwits - Mentions: TNMG GOSS RGBP BIXT ...

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

6 months ago - By: Yahoo Finance - Mentions: RNXT BBY KSCP BKNG ...

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

6 months ago - By: HeartSciences Inc.

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

6 months ago - By: HeartSciences Inc.

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

6 months ago - By: HeartSciences Inc.

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value

6 months ago - By: HeartSciences Inc.

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value

6 months ago - By: HeartSciences Inc.

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

6 months ago - By: HeartSciences Inc.

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

6 months ago - By: Heart Test Laboratories, Inc.

HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

6 months ago - By: Heart Test Laboratories, Inc.

HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

7 months ago - By: Heart Test Laboratories, Inc.

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

7 months ago - By: Heart Test Laboratories, Inc.

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

7 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

7 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

7 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

7 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

9 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

9 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

9 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

9 months ago - By: Heart Test Laboratories, Inc.

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

a year ago - By: Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

a year ago - By: Heart Test Laboratories, Inc.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

a year ago - By: Heart Test Laboratories, Inc.

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

a year ago - By: Heart Test Laboratories, Inc.

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement